Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Gilead Sciences Inc GILD

Sector: Healthcare | Sub-Sector: Biotechnology

Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.
Price: $91.55 | Change: $-2.24 | %Change: -2.39%
Volume: 13.4m | Day High/Low: 93.37/91.25 | 52 Week High/Low: 94.34/55.96

Snapshot

Last Traded: July 31, 2014 11:32 Transaction Volume: 10.1m
Open: $91.47 Previous Close: $93.79
Bid: $91.49 Ask: $91.50
Bid Size: 300 Ask Size: 200
Market Cap: $140.5b Shares Out: 1.5b
PE Ratio: 20.5 Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • US GDP growth

    0 stars

    up more than expected (4%) which may have spooked the mkt, because it may mean to some investors'  that QE will end sooner & rates will...

    2.5 stars


  • S & P target has not changed Just as a reminder

    0 stars

    Stock Report | June 28, 2014 | NNM Symbol: GILD | GILD is in the S&P 500 Gilead Sciences Inc S&P Capital IQ Recommendation STRONG...

    3 stars


  • FYI

    0 stars

    Gilead Submits New Drug Application to Japan’s Pharmaceutical and Medical Devices Agency for Sofosbuvir for Chronic Hepatitis C 2014-06...

    3 stars


  • A close over $82.

    0 stars

    would be nice. Opened above pivot point & broke thru $81.56. carlos

    2.5 stars


  • Vertex success

    0 stars

    vertex success in 2 drugs they have in trials may presage a summer rally in biotech stks according to some analysts & pull some dividend...

    2.5 stars